Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06919276 · ClinicalTrials.gov registry record · NA
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 3,048
- Enrollment target
NCT06919276: Completed NA study, sponsored by University of Southern California.
NCT06919276 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 3,048 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (117% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06919276, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,048 participants
- Enrollment target
Study Summary
This study assesses how the ways in which nicotine and cannabis vaping devices are labeled impact use susceptibility, anticipated effects, and health harm.
Primary Outcome
This 3-item self-report measure assesses participant interest in trying the vaping device in the future. A 4-level Likert scale is used: definitely not, probably not, probably yes, definitely yes.
Interventions
- OTHER Vaping Device Labeling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,048 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
What the finished NCT06919276 record still lists
NCT06919276 is an interventional study that assigns participants to a tested intervention. Its 3,048 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (117% higher).
The record links to 0 conditions, and to 1 intervention - of which Vaping Device Labeling is the first listed.
NCT06919276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06919276 about?
NCT06919276 is a clinical study titled "Nicotine and Cannabis Vape Labeling Experiment - Spring 2025". This study assesses how the ways in which nicotine and cannabis vaping devices are labeled impact use susceptibility, anticipated effects, and health harm.
What is the current status of trial NCT06919276?
This trial is currently completed. It is a NA study. The enrollment target is 3,048 participants. The study started on 2025-03-03. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT06919276?
The interventions under investigation include: Vaping Device Labeling (OTHER).
Who is sponsoring clinical trial NCT06919276?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06919276's enrollment target sits among peer trials
3,048 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI